Double-blind placebo-controlled trial of quetiapine in anorexia nervosa

European Eating Disorders Review

Volumn 20, Issue 4, 2012, Pages 331-334

  Powers, Pauline S ^a   Klabunde, Megan ^b   Kaye, Walter ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anorexia nervosa; pharmacotherapy; treatment; trial

Indexed keywords

PLACEBO; QUETIAPINE;

ADULT; ANOREXIA NERVOSA; ANXIETY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DSM-IV-TR; EATING DISORDER INVENTORY 2; FEMALE; HAMILTON SCALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSESSION; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATE TRAIT ANXIETY INVENTORY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYMPTOMATOLOGY; TREATMENT DURATION; WEIGHT GAIN; YALE BROWN CORNELL EATING DISORDER SCALE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; ANOREXIA NERVOSA; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES;

EID: 84862759767     PISSN: 10724133     EISSN: 10990968     Source Type: Journal    
DOI: 10.1002/erv.2169     Document Type: Review

References (21)

1. Bissada, H., Tasca, G., Barber, A., &, Bradwejn, J., (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 165, 1281-1288.
2. First, M., Spitzer, R., Gibbon, M., &, Williams, J., (November, 2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute.
3. Garner, D. M., Olmstead, M. P., &, Polivy, J., (1983). Development and validation of a multidimensional eating disorder inventory for anorexia and bulimia nervosa. International Journal of Eating Disorders, 2, 15-34.
4. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011. (Pubitemid 19278229)
5. Hamilton, M., (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62.
6. Hudson, J., Hiripi, E., Pope, H., Kessler, R., (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348-358. (Pubitemid 46108682)
7. Kafantaris, V., Leigh, E., Hertz, S., Berest, A., Schebendach, J., Sterling, W., et al. (2011). A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. Journal of Child and Adolescent Psychopharmacology, 21, 207-212.
8. Kaplan, A., &, Saddock, B. J., (1999). Comprehensive textbook of psychiatry. Philadelpia, PA: Lippincott Williams & Wilkins.
9. Kay, S. F., Fiszbein, A., &, Opler, L., (1987). The Positive and Negative Syndrome Scale (PANSS) of schizophrenia. Schizophrenia Bulletin, 13, 261-276. (Pubitemid 18039085)
10. Keys, A., Brozek, J., Henschel, A., Mickelsen, O., &, Taylor, H., (1950). The biology of human starvation. Minneapolis, MN: The University of Minnesota Press.
11. Mazure, C. M., Halmi, K. A., Sunday, S. R., Romano, S. J., &, Einhorn, A. M., (1994). The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. Journal of Psychiatric Research, 28, 425-445.
12. NICE. (2004). Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders (Clinical Guideline 9). London: National Collaborating Centre for Medical Health.
13. Nilsson, E. W., Gillberg, C., Gillberg, I. C., Gillberg, C., &, Rastam, M., (1999). Ten-year follow-up of adolescent-onset anorexia nervosa: Personality disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1389-1395. (Pubitemid 29513396)
14. Norris, M., Spettigue, W., Buchholz, A., Henderson, K., Gomez, R., Maras, D., et al. (2011). Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa. Journal of Child and Adolescent Psychopharmacology, 21, 213-220.
15. Powers, P., Bannon, Y., Eubanks, R., &, McCormick, T., (2007). Quetiapine in anorexia nervosa patients: An open label outpatient pilot study. International Journal of Eating Disorders, 40, 21-26. (Pubitemid 44936523)
16. Preti, A., Girolamo, G., Vilagut, G., Alonso, J., Graaf, R., Bruffaerts, R., et al. (2009). The epidemiology of eating disorders in six European countries: Results of the ESEMeD-WMH project. Journal of Psychiatric Research, 43, 1125-1132.
17. Sadock, B., &, Sadock, V., (1999). Kaplan and Sadock's comprehensive textbook of psychiatry, 7th ed. Chicago, IL: Lippincott Williams & Wilkins.
18. Spielberger, C. D., (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, Inc.
19. SPSS. (2001). SPSS for Windows, Rel. 11.0.1. edn, Chicago.
20. Sullivan, P. F., (1995). Mortality in anorexia nervosa. The American Journal of Psychiatry, 152, 1073-1074.
21. Yager, J., Devlin, M. H., Halmi, K. A., Herzog D., Mitchelolo J., Powes, P., et al. (2006). Practice guidelines for the treatment of patients with eating disorders, 3rd ed. American Psychiatric Association Practice Guideline for the Treatment of Psychiatric Disorders Compendium. Arlington, VA: American Psychiatric Association; pp. 1097-1222.